Alison Ower

Analyst, Evidence, Monitoring and Evaluation, Programs

Alison joined the END Fund in January 2021 and serves as an Analyst, Evidence, Monitoring and Evaluation for the Deworming Innovation Fund.

Prior to joining the END Fund, Alison was a member of the Neglected Tropical Disease (NTD) Epidemiology Research Group at Imperial College London, where her primary research objectives were centered on the epidemiology and control of soil-transmitted helminths (STH) in sub-Saharan Africa. Alison worked for three years as a Research Assistant on the Geshiyaro project, a large-scale deworming effort for STH and schistosomiasis in Ethiopia. The Geshiyaro project aims to interrupt the transmission of STH and schistosomiasis in the Wolayita zone through the implementation of expanded drug treatment, in combination with water and sanitation interventions. Her work focused on project evaluation and the development of data driven tools, with a particular interest in understanding trends in compliance to treatment.

Alison holds a MSc in Epidemiology with a focus in Infectious Disease Epidemiology from Imperial College London, and a BSc in Neuroscience from McGill University. Outside of the office, Alison enjoys spending time running, hiking, and cooking.